跳至主要内容
临床试验/NCT00768222
NCT00768222已完成4 期

Pilot Evaluation of Cosmetic Outcome and Surgical Site Infection Rates of Coated VICRYL* Plus Antibacterial (Polyglactin 910) Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery

Ethicon, Inc.6 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Ethicon, Inc.
入组人数
101
试验地点
6
主要终点
Mean Score on Cosmetic Outcome Visual Analog Scale (VAS)

研究概览

简要总结

This is a 90-day study to evaluate cosmetic outcome and Surgical Site Infection in approximately 100 patients from 6 centers in China undergoing scheduled modified radical mastectomy for breast cancer.

详细描述

Patients will be evaluated post-procedure on Days 3, 5, 7, 12, 30 and 90 for cosmetic outcome and surgical site infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older with written informed consent
  • Scheduled for a modified radical mastectomy
  • Surgical wound classified Class I/Clean using the CDC SSI Surgical Wound Classification

排除标准

  • Unable to give consent and unlikely to comply with study requirements and complete the 90-day follow up visit
  • Undergoing surgery for modified radical mastectomy with immediate breast reconstruction, cosmetic breast operations, reduction, expansion, insertion of prothesis, duct ectasia or infective breast disease or implant
  • Surgical wounds classified as Class II, III or IV using CDC SSI Surgical Wound Classification
  • Has inflammatory cancers or skin ulceration
  • Has known allergy or intolerance to triclosan
  • Has compromised wound healing or chronic immune deficiency, for example diabetes, prolonged steroid use, AIDS or substance abuse
  • Has serious heart and/or lung disease
  • Has skin scar history or family history
  • Has direct relationship to or involvement in this or other studies under the direction of the investigator or center
  • Received an experimental drug or device within 30 days prior to the planned start of treatment

结局指标

主要结局

Mean Score on Cosmetic Outcome Visual Analog Scale (VAS)

时间窗: 30 days (+/- 5) post-operative

Post-operative cosmetic outcome assessed on surgical site photographs by an independent blinded central assessor using a validated 100 mm visual analog scale, with 0 representing the worst possible scar and 100 representing the best possible scar

次要结局

  • Mean Cosmetic Outcome Score on Modified Hollander Scale(30 days)
  • Mean Surgical Site Infection Score on Modified ASEPSIS Scale(Day 90)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Coated VICRYL* Plus Suture Compared to Chinese Silk... | 临床试验